Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2004-01-06 - 2004-03-29
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: OECD guideline study according GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Swiss Federal Office of Public Health, 2003
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
435-580-8
EC Name:
-
Cas Number:
56553-60-7
Molecular formula:
C6H10BNaO6
IUPAC Name:
sodium bis(acetyloxy)boranuidyl acetate
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
- Name of test material (as cited in study report): Sodium triacetoxyborohydride
- Physical state: solid
- Analytical purity: 95%
- Lot/batch No.: LOT 30102
- Expiration date of the lot/batch: December 01, 2004
- Storage condition of test material: at room temperature at about 20°C, away from sunlight under nitrogen

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: CRR Ltd., Laboratory Animal Services, CH-4414 Füllinsdorf, Switzerland
- Age at study initiation: 10 – 11 weeks
- Weight at study initiation: mean 175.7
- Housing: In groups of three in Macrolon type-4 cages with wire mesh tops and standard softwood bedding (“Lignocell”, Schill AG, CH-4132 Muttenz, Switzerland
- Diet (e.g. ad libitum): Pelleted standard Provimi Kliba 3433 rat/mouse maintenance diet, batch No. 54/03 and 78/03 (Provimi Kliba AG, CH-4303 KAiseraugst, Switzerland); ad libitum
- Water (e.g. ad libitum): Community tap water from Füllinsdorf; ad libitum
- Fasting period before study: 15-19 h
- Acclimation period: not specified

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25
- Humidity (%): 30 - 70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 0.2, 0.03 g/mL
- Amount of vehicle (if gavage): 10 mL/kg
- Lot/batch no. (if required): 45256603

MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: based on previous non-GLP study
Doses:
300 and 2000 mg/kg bw
No. of animals per sex per dose:
300 mg/kg bw: 6 females
2000 mg/kg bw: 3 females
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations for mortality /viability daily during acclimatization and twice daily during day 1-5; observation for clinical signs daily during acclimatization and approx. 0, 1, 2, 3 and 5 h after administration, once during days 2-15; weighing on day 0 prior to administration, days 8 and 15
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
> 300 - < 2 000 mg/kg bw
Based on:
test mat.
Mortality:
All animals of the high dosage group were found dead 50 min - 60 min after administration and on day 2, respectively. All animals of the low dose groups survived.
Clinical signs:
2000 mg/kg bw: Moderate salivation, ruffled fur, sedation, ventral, recumbency, hunched posture, bluish discoloured feets and tail (only in 1 animal)
300 mg/kg bw: No clinical signs
Body weight:
All body weight were in normal range common for this strain.
Gross pathology:
2000 mg/kg bw: distended stomach with gas, discoloured left lateral lobe of liver, partly black forestomach and spleen, dark- red to black small intestine, pale to yellow discoloured kidneys
300 mg/kg bw: No macroscopic findings

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The LD50 of Sodium triacetoxyborohydride was found to be >300 and < 2000 mg/kg bw in female rats.
Executive summary:

Acute oral toxicity of Sodium triacetoxyborohydride was evaluated in a GLP study performed according to OECD 423, where groups of female Wistar rats were administered with 300 ad 2000 mg/kg bw in corn oil, respectively. Based on mortality and clinical signs observed in the high dose group, the LD50 was found to be >300 and < 2000 mg/kg bw.